The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global market for smart biopsy devices is projected to increase from $2.54 billion in 2022 to $2.73 billion in 2023, with a 7.6% CAGR. It is anticipated to reach $3.53 billion in 2027, growing at a 6.6% CAGR.

North America was the largest region in the smart biopsy devices market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

Smart Biopsy Devices Market Driver
“The increasing cancer cases are poised to drive the smart biopsy devices market’s growth. Cancer, a diverse group of diseases marked by uncontrolled cell growth and invasion, has amplified the demand for precise tissue samples. This has spurred the development of advanced smart biopsy tools with enhanced molecular, imaging, and precision capabilities for improved diagnosis and treatment planning. For example, in October 2022, the Australian Institute of Health and Welfare reported 1.58 million new cancer cases in Australia in 2021, up from 1.54 million in 2020, underscoring the market’s growth driven by rising cancer cases.

View More On The Smart Biopsy Devices Market Report 2023 – https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Prominent Smart Biopsy Devices Market Trend
Product innovation is a growing trend in the smart biopsy device market, with major companies focused on developing innovative solutions to enhance their market position. In April 2021, US-based IZI Medical Products LLC introduced the Quick-Core Auto Biopsy System for soft tissue biopsy, which offers the same reliability and accuracy as its semi-automatic predecessor while being portable and fully automatic, featuring a lightweight, compact design for one-handed use during procedures.

Smart Biopsy Devices Market Prominent Players
Major players in the smart biopsy devices market are Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Becton Dickinson and Company.

Request A Sample Of The Global Smart Biopsy Devices Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12271&type=smp

Key Smart Biopsy Devices Market Segments
The global smart biopsy devices market is segmented –
1) By Product: Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

The Smart Biopsy Devices Global Market Report 2023  provides a comprehensive overview on the smart biopsy devices market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Biopsy Devices Global Market Report 2023
Gastrointestinal Devices Global Market Report 2023
Interventional Radiology Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model